Found 11 matching trials
Three-year Follow-up Study of Subjects Who Participated in a Previous Lambda (BMS-914143) Chronic Hepatitis C Clinical Trial N/A The primary purpose of this study is to determine whether the hepatitis C v...
Show More Learn More & Join Trial
Safety and Efficacy Study of Pegylated Interferon Lambda Versus Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C PHASE3 The purpose of this study is to determine if 48 weeks of therapy with Pegyl...
Show More Location
Local Institution
Learn More & Join Trial
Pharmacokinetic Study of BMS-914143 in Participants With Normal Renal Function and Mild, Moderate, Severe and End-stage Renal Dysfunction PHASE1 The purpose of this study is to determine the effect of renal impairment on...
Show More Location
Clinical Pharmacology Of Miami Inc.
Learn More & Join Trial
Safety and Efficacy Study of Pegylated Interferon Lambda With and Without Daclatasvir, Compared to Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C Genotype 2 and 3 PHASE3 The purpose of this study is to determine if 24 weeks of treatment with Peg...
Show More Location
Mayo Clinic Arizona
Learn More & Join Trial
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen PHASE2 At least 1 dose of pegIFNλ will be identified which is safe, well tolerated...
Show More Location
Advanced Clinical Research Institute
Learn More & Join Trial
Safety and Efficacy Study in Subjects With Chronic HCV and Underlying Hemophilia PHASE3 The primary objective for this study is to evaluate the proportion of subje...
Show More Location
Stanford Boswell Clinic
Learn More & Join Trial
Efficacy and Safety Evaluation of a Regimen Consisting of Peginterferon Lambda-1a + Ribavirin + Daclatasvir (Lambda + RBV + DCV) in HCV Genotype 1b Treatment naïve Patients or Prior Relapsers to Peginterferon Alfa + Ribavirin (Alfa + RBV) Therapy PHASE3 The purpose of this study is to determine if treatment with Pegylated Inter...
Show More Location
Va Long Beach Healthcare System
Learn More & Join Trial
Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin PHASE2 Substudy C: The purpose of this substudy is to determine whether Lambda com...
Show More Location
Alamo Medical Research
Learn More & Join Trial
Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin PHASE2 The purpose of this study is to determine if combination therapy with Pegyl...
Show More Location
Mayo Clinic Hospital
Learn More & Join Trial
Safety and Efficacy Study of Peginterferon Lambda-1a vs. Peginterferon Alfa-2a, Plus Ribavirin in Subjects With Genotype 1 Hepatitis C PHASE3 The purpose of this study is to determine if 48 weeks of therapy with Pegin...
Show More Location
Local Institution
Learn More & Join Trial